Richard Greil

Paracelsus Medical University ORCID: 0000-0002-4462-3694

1

h-index

2

Publications

5,856

Citations

Publications

1 shown

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness , Kevin J. Harrington , Richard Greil +97 more

2019 The Lancet 2928 citations

Frequent Co-Authors

Barbara Burtness

Yale Cancer Center

Kevin J. Harrington

Institute of Cancer Research

Denis Soulières

Centre Hospitalier de l’Université de Montréal

Makoto Tahara

National Cancer Center Hospital East

Gilberto de Castro

Instituto do Câncer do Estado de São Paulo

Amanda Psyrri

National and Kapodistrian University of Athens

Researcher Info

h-index: 1
Publications: 2
Citations: 5,856
Institution: Paracelsus Medical University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-4462-3694

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.